ZOTA Q1 FY27 Results & Concall Summary: Key Takeaways (ZOTA)

ZOTA Q1 FY27 (Jun-2026 Qtr) Earnings call highlights: Key takeaways, performance, financial metrics, outlook and guidance, concerns and management tone.

  • ZOTA Financials
  • ZOTA Shareholding Pattern
  • ZOTA Earnings Documents
  • ZOTA Announcements
  • ZOTA Corporate Actions
  • ZOTA Bulk, Block & Insider Deals
  • ZOTA Delivery Data
  • ZOTA Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Zota Health Care Ltd (ZOTA) Q1FY27 Concall Summary - Jun-2026 Qtr

Performance Overview

  • The company reported a strong start to FY27, continuing the growth momentum from the previous two years, driven by the sustained expansion of its Dava India store network and increasing consumer acceptance of affordable healthcare solutions.
  • A key highlight was the significant expansion of the retail footprint, with the addition of 264 new Dava India stores in Q1, bringing the total to 2,825 stores nationwide and serving approximately 60 lakh customers during the quarter.
  • The company is strategically moderating the pace of new store additions in FY27 to focus on enhancing productivity, monitoring operational trends in recently added stores, and strengthening overall store-level execution for healthy, scalable long-term growth.
  • Investments were made to strengthen the broader healthcare ecosystem, including a right issue in its subsidiary Dava and Health Mart Limited and support for emerging platforms like Eucogenric and Skia through subsidiaries KMH Ventures and QX Aventures.
  • The company engaged Mahendra Singh Dhoni, Sunil Shetty, and Akshay Kumar as brand ambassadors to build brand awareness for Dava India and Zota Healthcare, leading to a significant, planned increase in marketing expenditures for the quarter.

Financial Metrics

Log in to Stocksigma to read the Financial Metrics section of this summary.

Operating Performance / Business Segments

Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.

Key Discussions & Insights

Log in to Stocksigma to read the Key Discussions & Insights section of this summary.

Outlook and Guidance

Log in to Stocksigma to read the Outlook and Guidance section of this summary.

Challenges / Concerns

Log in to Stocksigma to read the Challenges / Concerns section of this summary.

Industry / Competitive Landscape

Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.

Overall Summary

Log in to Stocksigma to read the Overall Summary section of this summary.

  • ZOTA Q1FY27 Concall Transcript
  • ZOTA Q1FY27 Management Mirror
  • ZOTA Q2FY27 Concall Summary (Sep-2026 Qtr)